Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
29 hedge funds and large institutions have $26.3M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
12% less funds holding
Funds holding: 33 → 29 (-4)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
38% less capital invested
Capital invested by funds: $42.6M → $26.3M (-$16.3M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$584K |
| 2 |
RL
RPO LLC
Stamford,
Connecticut
|
+$182K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$143K |
| 4 |
DCM
Difesa Capital Management
New York
|
+$97.1K |
| 5 |
ICM
Ionic Capital Management
New York
|
+$54.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$2.95M |
| 2 |
Walleye Capital
New York
|
-$1.01M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$541K |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$334K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$218K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $2K | -$1.35K | -935 | -42% |
|
27
Morgan Stanley
New York
| $2K | – | – | – |
|
|
LA
28
Linden Advisors
New York
| – | -$2.95M | -1,240,842 | Closed |
|
|
CL
29
CSS LLC
Chicago,
Illinois
| – | -$334K | -139,870 | Closed |
|
|
MP
30
MSD Partners
New York
| – | -$180K | -75,000 | Closed |
|
|
SM
31
Skaana Management
Brooklyn,
New York
| – | -$106K | -44,281 | Closed |
|
32
Jane Street
New York
| – | -$26K | -11,029 | Closed |
|
|
JAIC
33
Josh Arnold Investment Consultant
Edina,
Minnesota
| – | -$24K | -10,200 | Closed |
|
CANO.WS Hedge Fund Activity: Q1 2022 in Review
29 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q1 2022, worth a combined $26.3M — down 38% from $42.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CANO.WS and 2 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Barclays, opening a new position worth an estimated $584K. The largest seller was Linden Advisors, exiting entirely with an estimated $2.95M sold.
- 29 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q1 2022, down from 33 in Q4 2021.
- Funds reported $26.3M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q1 2022, down 38% quarter-over-quarter.
- 2 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q1 2022 and 6 closed out, a net change of -4 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q1 2022 was Barclays, an estimated $584K added.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q1 2022 was Linden Advisors, an estimated $2.95M sold.
Based on aggregated 13F filings for Q1 2022.